Drugs / Ucha-Shinki-Hwan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03790033 | Dec 2018 → Aug 2019 | — | Gachon University Gil Oriental Medical Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ucha-Shinki-Hwan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03790033 ↗ |
| Known as | UCHA | “Ucha-Shinki-Hwan (UCHA) is widely used in the treatment of various diseases including CHHF by harmonizing Yin and Yang, and improving the vitality of whole body.” PMID 32080084 ↗ Feb 2020 |